2nd trial for NET going into the world of CAR T-Cell

Lama Amer, Fellow at the University of Toronto, shared on X:

“2nd trial for NET going into the world of CAR T-Cell . Excited to see what the future holds

Phase I CAR T-cell clinical trial targeting the molecule IL13Rα2 found on surface of some tumors is being conducted at UCLA.

This trial investigates the safety and effectiveness of IL13Rα2 CAR T-cells in treating advanced melanoma and other solid tumors, such as neuroendocrine cancer, aiming to improve treatment options for advanced cancers.”

Source: Lama Amer/X